Supplemental Financial Information (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2013

Dec. 31, 2012

Supplemental Financial Information

Schedule of interest expense, net

	Three months ended March 31,
(in millions)	2013		2012
Interest expense	$72		$—
Interest income	(6	)	(1	)
Interest expense (income), net	$66		$(1	)

years ended December 31 (in millions)	2012			2011			2010
Interest and dividend income	$	(20	)	$	(20	)	$	(28	)
Interest expense		104			—			—
Interest expense, net	$	84		$	(20	)	$	(28	)

Schedule of accounts payable and accrued liabilities

as of December 31 (in millions)	2012		2011
Sales rebates	$	1,616	$	1,537
Accounts payable		556		417
Salaries, wages and commissions		523		435
Royalty license arrangements		398		417
Government investigation		—		1,509
Acquired IPR&D		—		400
Other		1,718		1,166
Accounts payable and accrued liabilities	$	4,811	$	5,881

Schedule of long-term liabilities

as of December 31 (in millions)	2012		2011
Deferred income taxes	$	360	$	646
Pension and other post-employment benefits		979		397
Other		900		617
Long-term liabilities	$	2,239	$	1,660

Schedule of accumulated other comprehensive income (loss)

(in millions) (brackets denote losses)	Foreign currency translation adjustments	Pension and post- employment benefits	Unrealized gains (losses) on marketable equity securities	Gains (losses) on hedging activities	Total
Balance as of December 31, 2012	$181	$(511)	$1	$(21)	$(350)
Other comprehensive income before reclassifications	(232)	—	(1)	9	(224)
Amounts reclassified from accumulated other comprehensive income	—	19	—	—	19
Net current-period other comprehensive income	(232)	19	(1)	9	(205)
Separation-related adjustments	241	(934)	—	11	(682)
Balance as of March 31, 2013	$190	$(1,426)	$—	$(1)	$(1,237)

as of December 31 (in millions) (brackets denote loss)	2012			2011
Cumulative foreign currency translation gain adjustments	$	181		$	8
Pension and other post-employment benefits		(511	)		(65	)
Cumulative unrealized gains on marketable equity securities		1			26
Cumulative losses/gains on derivative instruments designated as cash flow hedges		(21	)		6
Accumulated other comprehensive loss	$	(350	)	$	(25	)